Clinical Trials Logo

Hemorrhage clinical trials

View clinical trials related to Hemorrhage.

Filter by:

NCT ID: NCT03399123 Recruiting - Blood Loss Clinical Trials

Effect of Low Tidal Volume on Blood Loss During Laparoscopic Hepatectomy

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

To explore the effect of low tidal volume on blood loss and gas exchange during laparoscopic hepatectomy

NCT ID: NCT03397901 Recruiting - Anemia Clinical Trials

Transverse Colostomy for Refractory Hemorrhagic Chronic Radiation Proctitis: a Prospective Cohort Study

Start date: July 20, 2018
Phase: N/A
Study type: Interventional

Refractory rectal bleeding of chronic radiation proctitis (CRP) is still problematic and does not respond to medical treatments including reagents, endoscopic argon plasma coagulation (APC) or topical formalin. We proposed this prospective cohort study, to assess the efficacy and safety of colostomy in treating refractory hemorrhagic CRP with moderate to severe anemia, to provide higher-quality evidence of colostomy in these patients.

NCT ID: NCT03395730 Recruiting - Clinical trials for Postpartum Haemorrhage With Retained Placenta

Intraumbilical Oxytocin Versus Placental Cord Drainage in the Management of 3rd Stage of Labor

Start date: September 30, 2017
Phase: Phase 2
Study type: Interventional

The aim of this study is to compare the effectiveness of intraumbilical oxytocin and placental cord drainage in the management of third stage of labor. Does the use of intraumbilical vein oxytocin injection or the use of Placental cord drainage can cause a reduction of blood loss, Hb level drop, the length of the third stage of labor and the incidence of manual removal of the retained placenta during the third stage of labor in pregnant women after delivery of the infant?

NCT ID: NCT03394755 Completed - Thrombocytopenia Clinical Trials

Thrombosomes® in Bleeding Thrombocytopenic Patients

Start date: March 19, 2018
Phase: Phase 1
Study type: Interventional

The study evaluates the safety and potential early signals of efficacy of allogeneic Thrombosomes in bleeding thrombocytopenic patients

NCT ID: NCT03390530 Withdrawn - Clinical trials for Intraventricular Hemorrhage of Prematurity

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

IVHT4
Start date: January 18, 2022
Phase: Phase 3
Study type: Interventional

Brain bleed in premature infants damages the brain and survivors suffer from cerebral palsy (weakness in the extremities), cognitive deficits, and neurobehavioral disorders. In this clinical trial, investigators will test whether thyroxine (hormone from thyroid gland) treatment in premature infants with moderate-to-large brain bleeds show recovery in the brain structure on MRI evaluation at the time of discharge (44+/-1 weeks) and neurodevelopmental improvement at 2 years of age.

NCT ID: NCT03388970 Enrolling by invitation - Clinical trials for Intracerebral Haemorrhage in Cerebellum

Vitamin K1 in the Treatment of Spontaneous Intracerebral Hemorrhage

Start date: August 1, 2017
Phase: Early Phase 1
Study type: Interventional

In order to determine the effectiveness and safety of early vitamin K1 use in reducing the risk of bleeding and improving prognosis in patients with spontaneous intracerebral hemorrhage. Patients with spontaneous intracerebral hemorrhage (excluding rupture of aneurysm and vascular malformation) will be randomly divided into experimental group and control group. All the patients in the two groups were treated according to the guideline of spontaneous intracerebral hemorrhage. Patients in the experimental group was treated with intravenous injection of vitamin K1 20mg once a day for 2 days after admission, and the patients in control group was treated with normal saline as a control. The hematoma volume, coagulation function, platelet levels and GCS scales of the two groups will be recorded in 0d, 1d, 3d, 7d post bleeding stroke, furthermore, length of ICU stay and total hospitalization, incidence of complications during hospitalization are to be recorded. During the follow-up, mRS score will be recorded at 1m and 6m post bleeding stroke.

NCT ID: NCT03388125 Active, not recruiting - Clinical trials for Bleeding Esophageal Varices

Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection

Start date: January 1, 2016
Phase: Phase 3
Study type: Interventional

Endoscopic Injection Sclerotherapy vs N-butyl-2-cyanoacrylate Injection

NCT ID: NCT03385928 Completed - Clinical trials for Intracerebral Haemorrhage

STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units

Start date: March 19, 2018
Phase: Phase 2
Study type: Interventional

The study is a prospective phase II randomised, double-blind, placebo-controlled investigator-driven trial in acute intracerebral haemorrhage patients. The study has 2 arms with 1:1 randomisation to either intravenous tranexamic acid or placebo and will test the hypothesis that in patients with spontaneous ICH, treatment with tranexamic acid within 2 hours of onset will reduce haematoma expansion compared to placebo.

NCT ID: NCT03383562 Not yet recruiting - Infection Clinical Trials

Daytime Variation of Complication in Gastric and Pancreatic Surgery

Start date: January 1, 2018
Phase: N/A
Study type: Observational

Evaluate the daytime variation of complications in gastric and pancreatic surgery

NCT ID: NCT03382145 Recruiting - Clinical trials for Postmenopausal Bleeding

A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic

Start date: February 1, 2018
Phase:
Study type: Observational

Postmenopausal bleeding (PMB) is a common gynaecological complaint, accounting for up to 5 to 10 % of postmenopausal women being referred to gynaecological outpatient clinic. It also comprised of up to 10% of our outpatient gynaecological referral. In general, 60 % of women with postmenopausal bleeding have no organic causes identified, whilst benign causes of PMB includes atrophic vaginitis, endometrial polyp, submucosal fibroid and functional endometrium. However, between 5.7 to 11.5% of women with postmenopausal bleeding have endometrial carcinoma, which is the fourth most common cancer among women, therefore, it is important to investigate carefully to exclude genital tract cancer. A One-stop postmenopausal bleeding clinic has been established since February, 2002 by the Department of Obstetrics and Gynaecology, New Territories East cluster (NTEC) aiming at providing immediate assessment of women with postmenopausal bleeding in one single outpatient clinic assessment. During the visit, a detailed history was taken in regarding the PMB and usage of hormonal replacement therapy or herbal medicine. A physical examination was performed and a cervical smear was taken if not been taken within a year. Transvaginal ultrasound (TVS) was then performed to measure the endometrial thickness (ET), examining ovaries then followed by an endometrial sampling. An outpatient hysteroscopy was performed only if TVS showed an ET >= 5mm, or an abnormal endometrial appearance or unsatisfactory ET. Benign looking endometrial polyp would be removed during the outpatient hysteroscopy if possible. At the moment, there was very limited local data and lack of the long term result. Investigators aim to retrospectively evaluate the clinical outcome of postmenopausal bleeding patients who has attended One Stop Postmenopausal Clinic in order to formulate better care and counseling in future. Objectives: 1. To analyze histopathology in relative to history and ultrasound findings in PMB women presented to One Stop Postmenopausal Bleeding Clinic at NTEC 2. To correlate the clinical findings of transvaginal ultrasonography (TVS) with outpatient hysteroscopy and endometrial assessment in The One Stop Postmenopausal Bleeding Clinic 3. To identify predictive and prognostic factors in women with PMB for possible use in triaging high risk patients